iPS Cell Differentiation Prediction via Gene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is no marker or technique to predict the differentiation potential of undifferentiated induced pluripotent stem (iPS) cells into cartilage cells, making it difficult to select iPS cell lines with high differentiation potential, leading to inefficient cell culture and increased costs in regenerative medicine and basic research.

Innovation Solution

A method to predict the differentiation potential of undifferentiated iPS cells into cartilage cells based on gene expression data, using specific gene expression ratios and a discrimination model to identify genes with altered expression levels, allowing for the selection of iPS cell lines with high differentiation potential without requiring induced differentiation into neural crest cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If induced differentiation into neural crest cells and cartilage cells is performed to evaluate differentiation potential, then accurate prediction of cartilage differentiation capability is achieved, but time consumption and cost increase significantly

Engineering Contradiction:
Improvedifferentiation potential prediction accuracyVSAvoidtime for differentiation process
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by performing gene expression analysis on undifferentiated iPS cells before initiating the differentiation process. By measuring the expression levels of specific genes (including CD271 and other neural crest-related genes) in the undifferentiated state, the method predicts future differentiation potential without requiring the cells to actually differentiate, thus saving the time and resources that would be consumed by the full differentiation protocol.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If induced differentiation into neural crest cells is performed to select high-potential iPS cell lines, then differentiation potential can be assessed, but production cost and process complexity increase

Engineering Contradiction:
Improvedifferentiation potential assessment accuracyVSAvoiddifferentiation process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the essential predictive information from the complex differentiation process by identifying and measuring specific gene expression markers in undifferentiated cells. Instead of requiring the full differentiation protocol to assess potential, the method extracts predictive signals from gene expression data alone, thereby simplifying the overall process while maintaining assessment accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If gene expression analysis of undifferentiated iPS cells is performed to predict differentiation potential, then time and cost are reduced, but prediction accuracy must be maintained

Engineering Contradiction:
Improvecell culture efficiencyVSAvoiddifferentiation potential prediction accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent applies parameter changes by shifting the measurement parameter from post-differentiation phenotypic assessment to pre-differentiation gene expression levels. By changing what parameter is measured (from cartilage marker expression after differentiation to neural crest-related gene expression in undifferentiated cells), the method achieves rapid prediction while maintaining accuracy through the selection of predictive gene markers.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11603563B2Method of predicting differentiation potential of iPS cells into cartilage cells based on gene expression profiles
Publication Date: 2023.03.14 SHIMADZU CORP
  • US11603563B2 patent drawing
  • US11603563B2 patent drawing
  • US11603563B2 patent drawing

AI summary

Provided is a method of predicting differentiation potential of undifferentiated iPS cells into cartilage cells. Provided is a genetic marker for predicting differentiation potential of undifferentiated iPS cells into cartilage cells. A method of predicting differentiation potential of undifferentiated iPS cells into cartilage cells based on gene expression data of the undifferentiated iPS cells. A method of predicting differentiation potential of undifferentiated iPS cells into cartilage cells by predicting differentiation potential of the iPS cells into neural crest cells (NC cells) based on gene expression data of the undifferentiated iPS cells.